Data / Form D filings / SeLux Diagnostics, Inc.
SeLux Diagnostics, Inc.: Form D filings
SeLux Diagnostics, Inc., a biotechnology company in Charlestown, MA, filed 6 Form D notices with the SEC between 2018 and 2024. The latest, on February 13, 2024, reports $40 million sold of a $45 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 56 ROLAND STREET, SUITE 206, Charlestown, MA, 02129
- Phone
- (617) 945-9383
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1736293
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | New notice | $45,000,000 | $40,000,000 | $5,000,000 | 9 | Feb 1, 2024 | sec.gov |
| Feb 28, 2022 | New notice | $57,613,735 | $48,175,947 | $9,437,788 | 25 | Feb 11, 2022 | sec.gov |
| Jun 17, 2021 | New notice | $7,500,000 | $2,500,000 | $5,000,000 | 25 | Jun 7, 2021 | sec.gov |
| Oct 1, 2020 | New notice | $1,700,000 | $813,907 | $886,093 | 1 | Sep 18, 2020 | sec.gov |
| Sep 12, 2019 | New notice | $8,999,997 | $8,999,997 | 27 | Aug 29, 2019 | sec.gov | |
| Apr 10, 2018 | New notice | $25,000,002 | $23,500,001 | $1,500,001 | 5 | Mar 28, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michele Parker Healy | Executive Officer | |
| Jamie Parker Condie | Director | |
| Orhan Parker Gazelle | Director | |
| John Parker Wilson | Executive Officer | |
| Eric E. Stern | Executive Officer, Director | |
| Ingo Parker Chakravarty | Director | |
| Steven E. Lufkin | Executive Officer, Director | |
| James Parker Cassidy | Director | |
| Erich Parker Scheller | Director | |
| Adam Parker Steel | Executive Officer | |
| Aleksandar E. Vacic | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Feb 12, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SeLux Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.